Select Medical (SEM) Competitors

$27.87
+0.54 (+1.98%)
(As of 11:40 AM ET)

SEM vs. EHC, RARE, BHVN, AXNX, IRTC, NVST, PBH, TXG, IBRX, and IOVA

Should you be buying Select Medical stock or one of its competitors? The main competitors of Select Medical include Encompass Health (EHC), Ultragenyx Pharmaceutical (RARE), Biohaven (BHVN), Axonics (AXNX), iRhythm Technologies (IRTC), Envista (NVST), Prestige Consumer Healthcare (PBH), 10x Genomics (TXG), ImmunityBio (IBRX), and Iovance Biotherapeutics (IOVA). These companies are all part of the "medical" sector.

Select Medical vs.

Encompass Health (NYSE:EHC) and Select Medical (NYSE:SEM) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, community ranking, profitability and dividends.

Encompass Health received 158 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.70% of users gave Encompass Health an outperform vote while only 57.70% of users gave Select Medical an outperform vote.

CompanyUnderperformOutperform
Encompass HealthOutperform Votes
484
71.70%
Underperform Votes
191
28.30%
Select MedicalOutperform Votes
326
57.70%
Underperform Votes
239
42.30%

Encompass Health has higher earnings, but lower revenue than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Encompass Health$4.80B1.71$352M$3.4723.61
Select Medical$6.66B0.54$243.49M$1.9114.59

Encompass Health has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Comparatively, Select Medical has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.

Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.8%. Encompass Health pays out 17.3% of its earnings in the form of a dividend. Select Medical pays out 26.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Encompass Health presently has a consensus price target of $83.22, indicating a potential upside of 1.60%. Select Medical has a consensus price target of $34.40, indicating a potential upside of 23.03%. Given Encompass Health's higher probable upside, analysts clearly believe Select Medical is more favorable than Encompass Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Encompass Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13
Select Medical
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

97.3% of Encompass Health shares are held by institutional investors. Comparatively, 89.5% of Select Medical shares are held by institutional investors. 2.1% of Encompass Health shares are held by insiders. Comparatively, 17.5% of Select Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Encompass Health has a net margin of 7.33% compared to Encompass Health's net margin of 3.65%. Select Medical's return on equity of 17.69% beat Encompass Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Encompass Health7.33% 17.69% 6.24%
Select Medical 3.65%16.93%3.30%

In the previous week, Encompass Health had 2 more articles in the media than Select Medical. MarketBeat recorded 7 mentions for Encompass Health and 5 mentions for Select Medical. Select Medical's average media sentiment score of 1.36 beat Encompass Health's score of -0.06 indicating that Encompass Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Encompass Health
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Select Medical
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Encompass Health beats Select Medical on 16 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SEM vs. The Competition

MetricSelect MedicalHospitals IndustryMedical SectorNYSE Exchange
Market Cap$3.58B$4.19B$4.80B$17.46B
Dividend Yield1.85%1.31%5.47%3.58%
P/E Ratio14.5912.48180.2021.53
Price / Sales0.540.882,573.0610.29
Price / Cash7.468.4631.6614.95
Price / Book2.312.294.665.02
Net Income$243.49M$178.36M$101.46M$963.22M
7 Day Performance2.11%3.13%-0.15%1.85%
1 Month Performance-3.09%1.42%-5.62%-2.03%
1 Year Performance-3.90%-3.94%9.70%95.77%

Select Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EHC
Encompass Health
4.6504 of 5 stars
$79.98
-0.9%
$83.22
+4.1%
+26.1%$8.01B$4.80B23.0538,000Upcoming Earnings
Positive News
RARE
Ultragenyx Pharmaceutical
4.4213 of 5 stars
$42.31
-1.3%
$91.55
+116.4%
+3.4%$3.48B$434.25M-5.081,276Analyst Report
BHVN
Biohaven
3.6375 of 5 stars
$43.64
-2.5%
$52.00
+19.2%
+167.2%$3.56B$462.51M-7.71239Analyst Report
Insider Buying
AXNX
Axonics
3.164 of 5 stars
$67.34
+0.0%
$70.73
+5.0%
+11.0%$3.43B$366.38M-517.96797Positive News
IRTC
iRhythm Technologies
0.2839 of 5 stars
$109.85
+0.3%
$135.11
+23.0%
-18.7%$3.42B$492.68M-27.122,000Positive News
NVST
Envista
3.6522 of 5 stars
$19.78
+3.3%
$29.60
+49.6%
-48.3%$3.40B$2.57B-32.4312,800News Coverage
PBH
Prestige Consumer Healthcare
4.1167 of 5 stars
$68.06
-0.1%
$110.00
+61.6%
+12.2%$3.38B$1.13B-41.50560Analyst Revision
Positive News
TXG
10x Genomics
4.2403 of 5 stars
$30.80
-6.3%
$60.88
+97.6%
-48.2%$3.67B$618.73M-14.191,259Upcoming Earnings
News Coverage
Gap Up
IBRX
ImmunityBio
0.1137 of 5 stars
$4.92
-6.1%
$5.00
+1.6%
+84.3%$3.33B$620,000.00-4.24628News Coverage
IOVA
Iovance Biotherapeutics
4.672 of 5 stars
$11.92
+0.3%
$24.64
+106.7%
+98.2%$3.33B$1.19M-6.34557Positive News

Related Companies and Tools

This page (NYSE:SEM) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners